Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tonix Pharmaceuticals Holding Corp. - Common Stock (NQ:TNXP)

5.280 -0.090 (-1.68%)
Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 619,067
Open 5.450
Bid (Size) 5.280 (700)
Ask (Size) 5.500 (100)
Prev. Close 5.370
Today's Range 5.202 - 5.510
52wk Range 5.010 - 20.56
Shares Outstanding 11,776,542
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Phase 3 Data Showing TONMYA(R) Improves Fibromyalgia Symptoms and Physical Function
Via Investor Brand Network
NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Report Third-Quarter 2026 Financial Results Nov. 9
Via Investor Brand Network

Performance

52-Week Range 74.3% below 52-week high
5.280
5.0152W Low 20.5652W High
1 Week 4.2% below 1-week high
5.011W Low 5.511W High

Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) traded between $5.01 and $20.56 over the past 52 weeks and last traded at $5.28, 74.3% below its 52-week high. Over the past week it ranged between $5.01 and $5.51.

Past 12 Months
+2.9%
-46.7%
-44.5%
-57.4%
-68.1%
-72.9%
1W +$0.15
1M -$4.62
3M -$4.23
6M -$7.12
YTD -$11.27
1Y -$14.21

TNXP was -72.9% over the past year, -57.4% over six months, -68.1% year to date, +2.9% in the last week.

12 Months vs Market
TNXP
-72.9%
DIA
+9.6%
SPY
+12.0%
QQQ
+13.0%
IWM
+14.1%

Over the past 12 months TNXP returned -72.9% versus DIA (Dow) +9.6%, SPY (S&P 500) +12.0%, QQQ (Nasdaq 100) +13.0% and IWM (Russell 2000) +14.1%.

Volume & Liquidity 0.95× 3-mo avg
Today 619,067 3-mo avg 649.3K
1W
769.3K
1M
974.4K
3M
649.3K
6M
587.2K
YTD
519.6K
1Y
546.1K

TNXP most recently traded 619,067 shares against a 3-month average daily volume of 649.3K.

More News

Read More
TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present TONMYA(R) Fibromyalgia Data at 2026 World Congress on Pain
Via Investor Brand Network
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present TNX-801 Vaccine Platform at World Vaccine Congress Europe
Via Investor Brand Network
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Expands TONMYA(R) Medicare Coverage to 32 Million Lives
Via Investor Brand Network
News headline image
Tonix Pharmaceuticals Targets TONMYA Growth as Lyme Prevention Trial Nears ↗
Via MarketBeat
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Promotes Thomas Englese to Chief Commercial Officer
Via Investor Brand Network
NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Participate in Cantor 2026 Global Healthcare Conference
Via Investor Brand Network
News headline image
Tonix Pharmaceuticals Highlights TONMYA Sales Surge, Lyme and Depression Pipeline ↗
Via MarketBeat
News headline image
Tonix Pharmaceuticals (TNXP) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Tonix Pharmaceuticals Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
BioMedNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Q2 Revenue of $13.5 Million as TONMYA Sales Reach $11 Million
Via Investor Brand Network
NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Q2 Revenue of $13.5 Million as TONMYA Sales Reach $11 Million
Via Investor Brand Network
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Participate in August, September Investor Conferences
Via Investor Brand Network
TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Receives FDA Feedback for Lyme Disease Prevention Study
Via Investor Brand Network
MissionIRNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Schedules Second-Quarter 2026 Results Call for Aug. 10
Via Investor Brand Network
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Publishes Mpox Research Supporting TNX-801 Vaccine Development
Via Investor Brand Network
BioMedNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Expands TONMYA Medicare Coverage to 145 Million Lives
Via Investor Brand Network
NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Enrolls First Patient in Phase 2 Depression Trial
Via Investor Brand Network
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Participate in BTIG Infectious Disease Day 2026
Via Investor Brand Network
MissionIRNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Expands TONMYA Coverage to 52 Million Commercial Lives
Via Investor Brand Network
TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Real-World Data Highlighting Widespread Opioid Use Among Fibromyalgia Patients
Via Investor Brand Network
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Publishes Phase 1 TNX-1500 Data Supporting Advancement into Phase 2
Via Investor Brand Network
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Real-World Fibromyalgia Burden Data at ISPOR 2026
Via Investor Brand Network
TechMediaBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present Fibromyalgia Real-World Data at ISPOR 2026
Via Investor Brand Network

Frequently Asked Questions

Is Tonix Pharmaceuticals Holding Corp. - Common Stock publicly traded?
Yes, Tonix Pharmaceuticals Holding Corp. - Common Stock is publicly traded.
What exchange does Tonix Pharmaceuticals Holding Corp. - Common Stock trade on?
Tonix Pharmaceuticals Holding Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tonix Pharmaceuticals Holding Corp. - Common Stock?
The ticker symbol for Tonix Pharmaceuticals Holding Corp. - Common Stock is TNXP on the Nasdaq Stock Market
What is the current price of Tonix Pharmaceuticals Holding Corp. - Common Stock?
The current price of Tonix Pharmaceuticals Holding Corp. - Common Stock is 5.280
When was Tonix Pharmaceuticals Holding Corp. - Common Stock last traded?
The last trade of Tonix Pharmaceuticals Holding Corp. - Common Stock was at 10/29/26 04:00 PM ET
What is the market capitalization of Tonix Pharmaceuticals Holding Corp. - Common Stock?
The market capitalization of Tonix Pharmaceuticals Holding Corp. - Common Stock is 62.18M
How many shares of Tonix Pharmaceuticals Holding Corp. - Common Stock are outstanding?
Tonix Pharmaceuticals Holding Corp. - Common Stock has 62M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.